Clinical Trials

Drug Development Drug Efficacy Phase 3 Trials Randomized Controlled Trials Patient Care Research Studies Randomized Trials Phase 2 Trials Drug Safety Experimental Drugs

Waterdrop Reports Q4 and 2025 Profit Jump, Sets Cash Dividend

AI-driven insurance gains signal capacity for cash returns.

Stories older than 24h

Immutep Halts Phase III Lung Cancer Trial After Futility Call as Shares Crash

Early Trials of Gene Regulation Drug Cut Dravet Seizures by Up to 91%, NEJM Reports

Alpha-Synuclein Tied to Rapid Alzheimer’s Progression in Women, JAMA Study Finds

Fungal Mycelium Supplement Tied to Fewer COVID-19 Vaccine Side Effects and Longer Antibody Response

Pilot Trial Signals Low-Dose Lithium May Slow Verbal Memory Decline in Mild Cognitive Impairment

Aristotle Flags Guardant Health as Key Q4 Contributor on Strong Results, Acquisition News

California Dog's Alerts Lead to Early Cancer Diagnoses for Couple

Insmed Sets $1 Billion 2026 Brinsupri Target After Strong First Full Quarter

Compass Pathways’ Psilocybin Therapy Hits Phase 3 Goal in Treatment-Resistant Depression

Rare Stroke Symptom Spurs Awareness as Trial Tests Aspirin vs Clopidogrel After Brain Bleeds

Early Metformin Use Tied to Lower Long COVID Risk, New Commentary Finds

Genentech Licenses SanegeneBio RNAi Program in Deal Worth Up to $1.7 Billion

Four-Marker Blood Test Shows About 92% Accuracy for Early Pancreatic Cancer in Retrospective Study

Regeneron Beats Q4 and Charts 2026 Catalysts With FDA Decisions and Phase III Push

Randomized Trial Finds Solriamfetol Improves Alertness in Early-Morning Shift Workers

Merck Lifts Mid-2030s Revenue Goal to $70 Billion From Emerging Businesses

Cochrane Update Finds No Clear Benefit of Cannabis-Based Medicines for Neuropathic Pain

Novo’s Wegovy Pill Posts Quick Uptake, Boosting Shares as Oral GLP‑1 Battle Nears

UK Trial Finds FDA-Cleared ADHD Nerve Stimulation Ineffective in Children and Teens